A study investigated if observing positive drug effects on pain and mobility in another patient increases pain reduction and functional capacity in other patients.
Presenting at AHS 2022, researchers assessed the efficacy of a 1-year treatment period with ubrogepant 50 or 100 mg in patients with migraine attacks with mild and moderate or severe pain.
Medicare could have saved up to $3.6 billion in 2020 by purchasing drugs at Mark Cuban Cost Plus Drug Company online pharmacy prices.
Data for this study were sourced from the National Health Interview Survey (NHIS) which was conducted in 2019.
Researchers evaluated the therapeutic potential of topical cannabidiol (CBD) for treating pain associated with thumb basal joint arthritis.
Presenting at AHS 2022, researchers evaluated the real-world effectiveness of ubrogepant in combination with onabotulinumtoxinA to treat breakthrough migraine.
The USPSTF recommends against the use of beta carotene or vitamin E for prevention of CVD or cancer and finds that the evidence is insufficient for ascertaining the benefits and harms of multivitamin use.
The combined severe acute respiratory syndrome coronavirus 2 seroprevalence from infection or vaccination reached an estimated 94.7% in December 2021.
Pentoxifylline decreased pain in the setting of lower back pain with radiculopathy due to lumbar disc herniation.
This systematic review and Bayesian meta-analysis evaluated the relative efficacy of 18 oral pharmacotherapeutic interventions for diabetic peripheral neuropathy.